BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 185 found
  Current Search:  taxotere: 185     

HTML
100%
Geoff Hurst lends support to prostate cancer campaign
A new campaign highlighting the inequality of treatment in men with prostate cancer has been launched with the help of England football hero Geoff Hurst.

It aims to raise awareness of the fact that 7 out of 10 men with advanced prostate...

Pharmafocus:  Jul 3 2008 10:27AM
Matching: taxotere
Find similar documents
HTML
100%
Geoff Hurst lends support to prostate cancer campaign
A new campaign highlighting the inequality of treatment in men with prostate cancer has been launched with the help of England football hero Geoff Hurst.

It aims to raise awareness of the fact that 7 out of 10 men with advanced prostate...

Pharmafocus:  Jul 3 2008 10:23AM
Matching: taxotere
Find similar documents
HTML
100%
Adding Taxane to Anthracycline-Based Therapy Does Not Improve Outcomes
SAN ANTONIO-Giving a taxane following standard anthracycline-based chemotherapy for early breast cancer will not improve outcomes, suggest results of a 104-center, British study presented at the San Antonio Breast Cancer Symposium.

There...

Oncology Times:  Jul 2 2008 1:45AM
Matching: taxotere
Find similar documents
HTML
100%
Two New Herceptin-Containing Regimens Approved
The FDA has approved two new regimens containing trastuzumab (Herceptin) for the adjuvant treatment of HER2 node-positive or node-negative (ER/PR-negative or with one high-risk feature) breast cancer.

The first regimen, known as TCH ...

Oncology Times:  Jul 2 2008 1:43AM
Matching: taxotere
Find similar documents
HTML
100%
Celsion Corporation: Tumor Targeting Docetaxel Abstract Selected for Presentation at the 11th Liposome Researc
Tumor Targeting Docetaxel Abstract Selected for Presentation at the 11th Liposome Research Days Conference (NewsRx.com) -- CELSION CORPORATION (NASDAQ: CLN) announced that its docetaxel thermosensitive liposome preclinical study results will...
NewsRX:  Jun 25 2008 6:56PM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
Study seeks to determine if presence of certain gene impacts patient outcome MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.-- (BUSINESS WIRE) -- GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the...
SmartBrief:  Jun 24 2008 8:17AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation of a Phase 2 study evaluating satraplatin in combination with the steroid,...
Yahoo! Canada:  Jun 24 2008 7:13AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Initiates Mid-Stage Trial Of Satraplatin In Prostate Cancer Patients
(RTTNews) - GPC Biotech AG (GPCB: News, Chart, Quote ) said Tuesday that it has initiated a mid-stage trial to assess satraplatin in combination with the steroid, prednisone, in patients with metastatic hormone-refractory prostate cancer or...
RTTNews.com:  Jun 24 2008 4:42PM
Matching: taxotere
Find similar documents
HTML
100%
GPC starts Phase II study on satraplatin cancer drug with prednisone steroid
MARTINSRIED, Germany (Thomson Financial) - GPC Biotech AG.

said it started a Phase II study in the United States, testing its experimental drug satraplatin in combination with the steroid prednisone on prostate cancer patients that could...

Forbes.com:  Jun 24 2008 8:31AM
Matching: taxotere
Find similar documents
HTML
100%
GPC starts Phase II study on satraplatin cancer drug with prednisone steroid
MARTINSRIED, Germany (Thomson Financial) - GPC Biotech AG.

said it started a Phase II study in the United States, testing its experimental drug satraplatin in combination with the steroid prednisone on prostate cancer patients that could...

Interactive Investor International:  Jun 24 2008 7:40AM
Matching: taxotere
Find similar documents
HTML
100%
GPC starts Phase II study on satraplatin cancer drug with prednisone steroid
MARTINSRIED, Germany (Thomson Financial) - GPC Biotech AG.

said it started a Phase II study in the United States, testing its experimental drug satraplatin in combination with the steroid prednisone on prostate cancer patients that could...

FinanzNachrichten.de:  Jun 24 2008 7:35AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
GPC Biotech AG (Frankfurt Stock Exchange: GPC,GPCB) today announced the initiation of a Phase 2 study evaluating satraplatin in combination with the steroid, prednisone, in patients with metastatic hormone-refractory prostate cancer (HRPC)...
Houston Chronicle:  Jun 24 2008 6:44AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
Study seeks to determine if presence of certain gene impacts patient outcome MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.

-- (Business Wire) GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation...

Stockwatch:  Jun 24 2008 6:41AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation of a Phase 2 study evaluating satraplatin in combination with the steroid,...
Yahoo! Canada:  Jun 24 2008 6:38AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial
GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation of a Phase 2 study evaluating satraplatin in combination with the steroid, prednisone, in patients with metastatic hormone-refractory prostate cancer...
Business Wire via MSN Money:  Jun 24 2008 6:25AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation of a Phase 2 study evaluating satraplatin in combination with the steroid,...
Business Wire via Yahoo!:  Jun 24 2008 6:22AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
Study seeks to determine if presence of certain gene impacts patient outcome MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation of a...
Business Wire:  Jun 24 2008 6:14AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hor
(GMT+1) Study seeks to determine if presence of certain gene impacts patient outcome Martinsried/Munich (Germany) and Princeton, N.J., June 24, 2008 - (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the initiation of a Phase 2...
HUGIN Online:  Jun 24 2008 6:10AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refr
- GPC Biotech AG announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, an oral platinum compound.

The patent is entitled, 'Satraplatin for treating resistant or refractory tumors' and covers certain uses of...

Bionity.com:  Jun 16 2008 11:03PM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech gets EU patent for satraplatin
GPC Biotech AG announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, a novel, oral platinum compound.

The patent is entitled, 'Satraplatin for treating resistant or refractory tumours' and covers certain...

PharmaBiz:  Jun 16 2008 11:07AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refr
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.-- (BUSINESS WIRE) -- GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, a novel, oral...
SmartBrief:  Jun 12 2008 9:54AM
Matching: taxotere
Find similar documents
HTML
100%
New Roche data to be presented at ASCO offers further hope for cancer patients
Basel, 15th May 2008 - Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin (bevacizumab) and Herceptin (trastuzumab) following new data that is being presented...
PharmiWeb:  Jun 12 2008 11:54AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refr
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.

- (Business Wire) GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, a novel, oral...

Earthtimes.org:  Jun 12 2008 8:52AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refr
GPC Biotech AG (Frankfurt Stock Exchange: GPC;GPCB) today announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, a novel, oral platinum compound.

The patent is entitled, "Satraplatin for treating resistant or...

Houston Chronicle:  Jun 12 2008 8:23AM
Matching: taxotere
Find similar documents
HTML
100%
GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refr
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced the granting of a European Patent (EP 1 720 540 B1) related to satraplatin, a novel, oral...
Yahoo! Canada:  Jun 12 2008 8:17AM
Matching: taxotere
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.